Literature DB >> 28758800

Dosing antibiotics in neonates: review of the pharmacokinetic data.

Nazario D Rivera-Chaparro1,2, Michael Cohen-Wolkowiez1,2, Rachel G Greenberg1,2.   

Abstract

Antibiotics are often used in neonates despite the absence of relevant dosing information in drug labels. For neonatal dosing, clinicians must extrapolate data from studies for adults and older children, who have strikingly different physiologies. As a result, dosing extrapolation can lead to increased toxicity or efficacy failures in neonates. Driven by these differences and recent legislation mandating the study of drugs in children and neonates, an increasing number of pharmacokinetic studies of antibiotics are being performed in neonates. These studies have led to new dosing recommendations with particular consideration for neonate body size and maturation. Herein, we highlight the available pharmacokinetic data for commonly used systemic antibiotics in neonates.

Entities:  

Keywords:  aminoglycoside; anti-infective agents; carbapenem; cephalosporins; drug dosing; infant; neonate; pharmacokinetics; preterm; β-lactams

Mesh:

Substances:

Year:  2017        PMID: 28758800      PMCID: PMC5627030          DOI: 10.2217/fmb-2017-0058

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.553


  99 in total

Review 1.  A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.

Authors:  M A Pfaller; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1997-08       Impact factor: 2.803

2.  Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.

Authors:  Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Ron A Mathot
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

3.  Pharmacokinetic study of piperacillin in newborns relating to gestational and postnatal age.

Authors:  N Kacet; M Roussel-Delvallez; C Gremillet; J P Dubos; L Storme; P Lequien
Journal:  Pediatr Infect Dis J       Date:  1992-05       Impact factor: 2.129

Review 4.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

5.  Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group.

Authors:  C M Odio; J R Puig; J M Feris; W N Khan; W J Rodriguez; G H McCracken; J S Bradley
Journal:  Pediatr Infect Dis J       Date:  1999-07       Impact factor: 2.129

6.  Population pharmacokinetics of cefepime in the neonate.

Authors:  Edmund Capparelli; Christine Hochwald; Maynard Rasmussen; Amy Parham; John Bradley; Fernando Moya
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Drug labeling and exposure in neonates.

Authors:  Matthew M Laughon; Debbie Avant; Nidhi Tripathi; Christoph P Hornik; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith; William Rodriguez
Journal:  JAMA Pediatr       Date:  2014-02       Impact factor: 16.193

8.  Pharmacokinetics of amoxicillin and ampicillin: crossover study of the effect of food.

Authors:  F N Eshelman; D A Spyker
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

9.  Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

Authors:  Susan M Abdel-Rahman; David P Benziger; Richard F Jacobs; Hasan S Jafri; Erica Fischer Hong; Gregory L Kearns
Journal:  Pediatr Infect Dis J       Date:  2008-04       Impact factor: 2.129

10.  Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.

Authors:  Adriana Tremoulet; Jennifer Le; Brenda Poindexter; Janice E Sullivan; Matthew Laughon; Paula Delmore; Andrea Salgado; Sandy Ian-U Chong; Chiara Melloni; Jamie Gao; Daniel K Benjamin; Edmund V Capparelli; Michael Cohen-Wolkowiez
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.938

View more
  3 in total

Review 1.  Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research.

Authors:  Swantje Voller; H Rob Taal; Serife Kurul; Kinga Fiebig; Robert B Flint; Irwin K M Reiss; Helmut Küster; Sinno H P Simons
Journal:  Pediatr Res       Date:  2021-09-08       Impact factor: 3.756

2.  Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units.

Authors:  Anouk van der Veen; Annemie Somers; Sophie Vanhaesebrouck; Rob Ter Heine; Roger Brüggemann; Karel Allegaert; Pieter De Cock
Journal:  Int J Clin Pharm       Date:  2021-11-02

3.  Deciphering risk factors for blood stream infections, bacteria species and antimicrobial resistance profiles among children under five years of age in North-Western Tanzania: a multicentre study in a cascade of referral health care system.

Authors:  J Seni; A A Mwakyoma; F Mashuda; R Marando; M Ahmed; R DeVinney; J D D Pitout; S E Mshana
Journal:  BMC Pediatr       Date:  2019-01-26       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.